Stonepine Capital Management’s CalciMedica CALC Stock Holding History

Stonepine Capital Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$545K	Buy	+124,486	New	+$441K	0.31%	62
2025 Q3	–	Sell	-17,000	Closed	-$136K	–	62
2025 Q2	$136K	Sell	17,000 -56,474	-77%	-$485K	0.13%	55
2025 Q1	$615K	Sell	73,474 -20,285	-22%	-$253K	0.6%	33
2024 Q4	$1.66M	Buy	+93,759	New	+$1.64M	1.34%	22
2024 Q2	–	Sell	-104,520	Closed	-$2.17M	–	26
2024 Q1	$2.17M	Buy	+104,520	New	+$2.39M	1.72%	11

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Stonepine Capital Management's CALC Position: Q2 2026 in Review

Stonepine Capital Management opened a new position in CalciMedica (CALC) in Q2 2026: 124,486 shares worth $545K. The stake represents 0.31% of the portfolio and ranks #62 among its holdings. This is a return to the name: Stonepine Capital Management previously reported a position in CALC as recently as Q2 2025.

Stonepine Capital Management first reported a position in CALC in Q1 2024 and has held it in 5 quarters since. The position peaked at $2.17M in Q1 2024. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

Stonepine Capital Management held 124,486 shares of CalciMedica worth $545K as of Q2 2026.
CalciMedica was a new Stonepine Capital Management position in Q2 2026.
CalciMedica made up 0.31% of Stonepine Capital Management's portfolio in Q2 2026, its #62 holding.
Stonepine Capital Management first reported a position in CalciMedica in Q1 2024 and has held it in 5 quarters since.
Stonepine Capital Management's CalciMedica position peaked at $2.17M in Q1 2024.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.